Waters Net Long-Term Debt 2010-2025 | WAT

Waters net long-term debt for the twelve months ending March 31, 2025 was $-1.260B, a 144.06% decline year-over-year.

  • Waters annual net long-term debt for 2024 was $-0.73B, a 193.59% decline from 2023.
  • Waters annual net long-term debt for 2023 was $0.78B, a 1200% increase from 2022.
  • Waters annual net long-term debt for 2022 was $0.06B, a 62.5% decline from 2021.

Waters Net Long-Term Debt 2010-2025 | WAT

  • Waters annual net long-term debt for 2024 was $-0.73B, a 193.59% decline from 2023.
  • Waters annual net long-term debt for 2023 was $0.78B, a 1200% increase from 2022.
  • Waters annual net long-term debt for 2022 was $0.06B, a 62.5% decline from 2021.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$183.7B
Thermo Fisher Scientific (TMO)$157.2B
Edwards Lifesciences (EW)$44.7B
Alcon (ALC)$42.9B
IDEXX Laboratories (IDXX)$41.9B
DexCom (DXCM)$33B
IQVIA Holdings (IQV)$27.4B
Mettler-Toledo (MTD)$24.6B
STERIS (STE)$22.4B
SONOVA HOLDING (SONVY)$17.3B
Hologic (HOLX)$14.2B
Sysmex ADR (SSMXY)$10.5B
Penumbra (PEN)$9.1B
Masimo (MASI)$8.6B
Globus Medical (GMED)$7.7B
Glaukos (GKOS)$5.6B
Teleflex (TFX)$5B
Integer Holdings (ITGR)$4.1B
TransMedics (TMDX)$3.8B
PROCEPT BioRobotics (PRCT)$3.2B
LivaNova (LIVN)$2.3B
Nihon Kohden (NHNKY)$2.2B
Veracyte (VCYT)$2B
Elekta AB (EKTAY)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1.1B
Tandem Diabetes Care (TNDM)$1B